All Life Sciences & Technology News
Top stories summarized by our editors
6/28/2017

The FDA granted approval to Cadila Healthcare's entecavir tablets as a treatment for patients with hepatitis B virus. The drug will be manufactured at the company's formulations manufacturing facility in Ahmedabad, India.

Full Story:
Reuters
More Summaries:
FDA, Cadila Healthcare
6/28/2017

KaloBios Pharmaceuticals' investigational new drug application for benznidazole as a treatment for patients with Chagas disease received FDA approval. KaloBios intends to file a new-drug application in the first quarter next year under the abbreviated 505(b)(2) pathway.

6/28/2017

A $20 million Series A funding round will allow Mitoconix Bio to start clinical studies of its lead candidate, MTC-1203, intended to treat Huntington's disease, sometime in 2019.

Full Story:
BioCentury
More Summaries:
Mitoconix Bio, Series A
6/28/2017

Sarepta Therapeutics opened its Andover, Mass.-based Research and Manufacturing Center, which will initially start development of up to seven investigational Duchenne muscular dystrophy drugs by the end of the year. Included in the Sarepta pipeline to be advanced in the facility are late-stage-ready DMD treatments that skip exon 53 and exon 45, a preclinical candidate that skips exon 52 and discovery-phase candidates designed to skip exons 8, 35, 43, 44, 50, and 55.

6/28/2017

Researchers from China have developed purple biotech rice that can reduce the risk of cardiovascular disease, diabetes, certain cancers and other chronic disorders. Scientists used a transgene stacking system called TransGene Stacking II that assembles a large number of genes in single vectors so that the plants produce high levels of anthocyanins.

More Summaries:
China
6/28/2017

The Institute of Chemical Technology Mumbai and L&T Hydrocarbon Engineering have agreed to collaborate to build second-generation ethanol plants in India. Under the deal, L&T will provide construction and engineering services while the institute will provide its multifeedstock technology.

6/28/2017

An investigational new drug application has been filed by Trovagene for its Phase Ib/II study assessing PCM-075 for treatment of acute myeloid leukemia.

Full Story:
Reuters
More Summaries:
FDA, Trovagene
6/28/2017

Almirall has been granted approval by the European Commission for its oral dimethyl fumarate therapy Skilarence for use as a first-line induction and maintenance treatment for adult patients with moderate to severe plaque psoriasis. Almirall intends to commercialize the drug in Iceland, Norway and all EU states in the third quarter.

6/28/2017

Janssen's continuous manufacturing with real-time release testing for the production of 600-mg Prezista, or darunavir, tablets has been approved by the European Medicines Agency. The process will occur at Janssen's Gurabo, Puerto Rico, production plant.

6/28/2017

About 61,538 pounds of Sam's Choice Asian Style Beef Wonton Ravioli were recalled by Wornick because they might include milk as an undeclared ingredient. The recalled products were distributed nationwide to retail stores.